Stockreport

OKYO Pharma Limited's (NASDAQ:OKYO) Intrinsic Value Is Potentially 90% Above Its Share Price [Yahoo! Finance]

OKYO Pharma Limited - Ordinary Shares  (OKYO) 
PDF Our fair value estimate is 45% lower than OKYO Pharma's analyst price target of US$8.33 Today we will run through one way of estimating the intrinsic value of OKYO Ph [Read more]